Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)
** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **
· Learners will assemble a step-wise therapy approach to prevent COPD exacerbation and increase the quality of life/decrease dyspnea.
· Learners will articulate specific medication names in order to better apply combination therapy to reduce the burden of medication load on patient.
· Learners will identify steps within medication algorithms that combination therapies could reduce the financial burden and increase compliance.
· Learners will convey to patients the impact that optimized COPD management has on quality of life and exacerbation frequency.
· Giving medication names and not classes alone will help and allow learners to apply combination therapy to reduce the burden of medication load to a patient.
· Learners will reconstruct the way we assemble medication algorithms to create more room for increased compliance by decreasing the number of inhalers used, which in many cases, reduces the financial burden of patients.
· Learners will improve the quality of life of their patients and decrease their exacerbation by applying effective combination therapies and assembling a stepwise therapy approach to treating and preventing COPD.
Accreditation Statement: Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A CME credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure: The Missouri Association of Osteopathic Physicians and Surgeons Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients relative to the content of this presentation.
Grievance Policy: All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|Handout - Sa7B) Dr. Joseph Carrington - Practical Management of COPD (24.42 MB)
|Available after Purchase
Dr. Joseph Carrington is an Iowa native and a graduate of Des Moines University College of Osteopathic Medicine. He earned a dual-degree Doctorate in Osteopathic Medicine and a Master's in Healthcare Administration. Dr. Carrington went on to do his internal medicine residency at the Johns Hopkins University/ Sinai Hospital of Baltimore in Baltimore, Maryland. He completed his fellowship in pulmonary medicine and critical care medicine at the University of Nebraska Medical Center in Omaha, Nebraska. During his fellowship, he also served as Chief Fellow and was awarded "research fellow of the year" and "house officer of the year." Dr. Carrington is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine by the American Board of Internal Medicine.
His research interests were in the inflammatory pathways of inhalational lung injury and recovery, including IL-6 and IL-10. His research was presented at the American College of Chest Physicians annual conference, where he was awarded for being one of the top 5 presentations that year. Returning to Iowa, Dr. Carrington now works as an intensivist and pulmonologist at MercyOne in Des Moines, Iowa.
Dr. Carrington discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients relative to the content of this presentation.